Portfolio News March 12, 2015 Interleukin 1 Gene Variations Interact With Obesity to Predict Periodontitis Progression
Portfolio News March 12, 2015 Epizyme Reacquires Global Rights from Eisai for First-in-Class EZH2 Inhibitor EPZ-6438
Portfolio News March 12, 2015 Interleukin 1 Gene Variations Interact With Obesity to Predict Periodontitis Progression
Portfolio News March 9, 2015 Interleukin Genetics Expands its Collaboration with Isis Pharmaceuticals
Portfolio News February 10, 2015 Hyperion Therapeutics Initiates Clinical Study to Further Evaluate RAVICTI(R)
Portfolio News February 5, 2015 Dermira Announces Positive Phase 2b Results for DRM04 in Patients with Hyperhidrosis
Portfolio News February 4, 2015 Merus Starts Phase I/II Clinical Trial for MCLA-128, an ADCC-enhanced Bispecific Antibody for Solid Tumors
Portfolio News January 22, 2015 Nevro Receives Approvable Letter from U.S. Food and Drug Administration for Senza® Spinal Cord Stimulation System
Portfolio News January 14, 2015 EnteroMedics Announces FDA Approval of VBLOC(R) Vagal Blocking Therapy for the Treatment of Obesity
Portfolio News January 8, 2015 Dermira and UCB Announce Start of Phase 3 Program for CIMZIA(R) (certolizumab pegol) in Psoriasis
Portfolio News January 8, 2015 Conatus Announces Top-Line Results From ACLF and Organ Impairment Clinical Trials of Emricasan
Portfolio News January 7, 2015 Interleukin Announces Collaboration with Isis Pharmaceuticals for Genetic Testing Services
Portfolio News January 7, 2015 Reset Therapeutics Announces Expansion of its Drug Discovery Platform via an Agreement with 23andMe